Drug Trial Radar · NCT06109441
Efficacy/Safety of ALTB-268 in Subjects w/Moderately to Severely Active UC Refractory to Biologics
Last checked: Nov 19, 2026Latest source record: May 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
50
Planned (sponsor's estimate)
Start
Dec 4, 2023
Primary completion
Mar 5, 2026
Study completion Mar 2028
Sponsor
- Lead sponsor
- AltruBio Inc.Industry
- Sponsor type
- Industry
- First posted
- Oct 31, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
ALTB-268-201 is a Phase 2a, multicenter, single arm, multiple-dose, open-label study evaluating the efficacy and safety of ALTB-268 in subjects with moderately to severely active UC. The study consists of a Screening Phase, an Induction Phase and a LTE (Long Term Extension)
Conditions
- Ulcerative Colitis
Interventions
ALTB-268Biological
ALTB-268 drug product (DP) for SC injection is supplied as a sterile and preservative-free frozen solution or lyophilized powder. All excipients used in the DP formulation are of multi-compendial quality and have precedence for use in parenteral products.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Efficacy - change in mMSTime frame: week 12
Locations
24 sites in 2 countries. Site status is shown where the registry gives one.
San Diego Gastroenterology
San Diego, California
Rocky Mountain Gastroenterology
Littleton, Colorado
Gastro Health Research
Miami, Florida
Digestive and Liver Center of Florida, LLC
Orlando, Florida
Alliance Clinical Research of Tampa, LLC.
Tampa, Florida
Gastro Health Partners Southern Indiana
New Albany, Indiana
Gastro Health Partners Louisville
Louisville, Kentucky
Louisiana Research Center, LLC.
Shreveport, Louisiana
Gastroenterology Associates of North Mississippi
Oxford, Mississippi
New York Presbyterian Hospital - Weill Cornell Medical Colllege
New York, New York
Gastroenterology Group of Rochester
Rochester, New York
Digestive Disease Medicine of Central New York
Utica, New York
Dayton Gastroenterology, LLC
Beavercreek, Ohio
Gastro Health Ohio
Liberty Township, Ohio
Frontier Clinical Research, LLC
Uniontown, Pennsylvania
Gastroenterology Associates, P.A.
Greenville, South Carolina
DHAT / GI Aliance
Garland, Texas
Caprock Gastro Reasearch
Lubbock, Texas
GI Alliance
Mansfield, Texas
Southern Star Research Institute LLC
San Antonio, Texas
Tyler Research Institute
Tyler, Texas
GI Alliance
Webster, Texas
Wisconsin Center for Advanced Research
Milwaukee, Wisconsin
Wellness Clinical Research, LLC
Vega Baja, Puerto Rico
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.